Madeline Begemann

MB

Statistics

Publications

1

Citations

15

H-Index

1

Active since

2019

Affiliations

Madeline Begemann is an author at Rush University Medical Center specializing in cancer immunotherapy, programmed death-ligand 1 inhibitors, and pd-l1 blockade.

Publications per year

2019–2019

1

Publications

1